FDA Clearance Tracker · P010013-S019
NOVASURE IMPEDANCE CONTROLLED ENDOMETRIAL ABLATION SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 1, 2008 (this decision)Source: openFDAMethods & limitations
Decided
Feb 1, 2008
Approved
Time to decision
50 days
Received Dec 13, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P010013-S019
- Device name
- NOVASURE IMPEDANCE CONTROLLED ENDOMETRIAL ABLATION SYSTEM
- Applicant
- Hologic, Inc.
- Applicant location
- Malborough, MA
- Received
- Dec 13, 2007
- Decided
- Feb 1, 2008
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P010013
Device type
- Device type
- Device, thermal ablation, endometrial (MNB)
- Device class
- Class III
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MANUFACTURING SITE LOCATED AT CYTYC CORPORATION, MARLBOROUGH, MASSACHUSETTS.
Source documents
Other decisions for Hologic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- I-View®510(k)
K254090 · Decided Sep 2, 2026 · 257 days after receipt
Device type: Full Field Digital, System, X-Ray, Mammographic (MUE) · Radiology & Imaging
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.